Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pregnancy & Endocrinology William Harper Hamilton General Hospital McMaster University www.drharper.ca.

Similar presentations


Presentation on theme: "Pregnancy & Endocrinology William Harper Hamilton General Hospital McMaster University www.drharper.ca."— Presentation transcript:

1 Pregnancy & Endocrinology William Harper Hamilton General Hospital McMaster University

2 Objectives Thyroid Disorders & Pregnancy Normal thyroid phsyiology & pregnancy Hypothyroidism & pregnancy Thyrotoxicosis & pregnancy Postpartum thyroid dysfunction Diabetes & Pregnancy Gestational DM Type 1 & Type 2 DM & Pregnancy

3 Case 1 31 year old female Somalia  Canada 3 years ago G2P1A0, 11 weeks pregnant Well except fatigue Hb 108, ferritin 7 (Fe and LT4 interaction?) TSH 0.2 mU/L, FT4 7 pM Started on LT  TSH < 0.01 mU/L FT4 12 pM, FT3 2.1 pM

4 Case 1 1. How would you characterize her hypothyroidism? 2. What are the ramifications of pregnancy to thyroid function/dysfunction?

5

6 TSH Low High FT4 FT4 & FT3 Low 1° Hypothyroid Low Central Hypothyroid TRH Stim. If equivocal MRI, etc. High 1° Thyrotoxicosis High 2° thyrotoxicosis Endo consult FT3, rT3 MRI, α-SU RAIU

7 Case 1 GH, IGF-1 normal LH, FSH, E2, progesterone, PRL normal for pregnancy 8 AM cortisol 345, short ACTH test normal MRI: normal pituitary TGAB, TPOAB negative Normal pregnancy, delivery, baby, lactation

8 Thyroid & Pregnancy: Normal Physiology Increased estrogen  increased TBG (peaks wk 15-20) Higher total T4 & T3: normal FT4 & FT3 if normal thyroid fn. and good assay many automated FT4 assays underestimate true FT4 level (except Nichols equilibrium dialysis free T4 assay) if suspect your local FT4 assay is underestimating FT4 can check total T4 & T3 instead (normal pregnant range ~ 1.5x nonpregnant) hCG peak end of 1 st trimester, hCG has weak TSH agonist effect so may cause: slight goitre mild TSH suppression ( mU/L) in 9% of preg mild FT4 rise in 14% of preg

9 Thyroid & Pregnancy: Normal Physiology Fetal thyroid starts working at wks T4 & T3 cross placenta but do so minimally Cross placenta well: MTZ > PTU TSH-R Ab (stim or block) ATD (PTU & MTZ): Fetal goitre (can compress trachea after birth) MTZ  aplasia cutis scalp defects Other MTZ reported embryopathy: choanal atresia, esophageal atresia, tracheo-esophageal fistula Therefore do NOT use MTZ during pregnancy, use PTU instead

10

11 No TSH  & FTI  at end of 1 st trimester as expected from hCG effect Requirement to increase LT4 dose occurred between weeks Despite exponential rise in estradiol throughout pregnancy (note y-axis units) TBG levels plateau at 20 wks

12 LT4 dose requirement tied to rising TBG levels (THBI inversely proportional to TBG level) By 10 wks need average increase of 29% LT4 dose By 20 wks need average increase of 48% LT4 dose No increase of dose beyond 20 wks required

13 * Regardless of cause of hypothyroidism (Hashimoto’s, thyroidectomy) initial LT4 dose increase is usually required early (~ week 8), before 1 st prenatal visit!

14 Thyroid & Pregnancy: Hypothyroidism 85% will need increase in LT4 dose during pregnancy due to increased TBG levels (ave dose increase 48%) Risks: increased spont abort, HTN/preeclampsia, abruption, anemia, postpartum hemorrhage, preterm labour, baby SGA Fetal neuropsychological development (NEJM, 341(8): , Aug 31, 2001): –Cognitive testing of children age 7-9 –Untreated hyothyroid mothers vs. normal mothers: Average of 7 IQ points less in children Increased risk of IQ < 85 (19% vs. 5%) –Retrospective study, data-dredging?

15 LT4 dose adjustment in Pregnancy: - Optimize TSH preconception (0.4 – 2.5 mU/L) - TSH at pregnancy diagnosis (~3-4 wk gestation), q1mos during 1 st 20 wks and after any LT4 dose change, q2mos 20 wks to term - Instruct women to take 2 extra thyroid pills/wk (q Mon, Thurs) for 29% dose increase once pregnancy suspected (+ commercial preg test) - If starting LT4 during preg: initial dose 2 ug/kg/d and recheck TSH q4wk until euthythyroid TSHDose Adjustment TSH increased but < 10 Increase dose by 50 ug/d TSH Increase dose by ug/d TSH > 20 Increase dose by 100 ug/d

16 Pregnancy: screen for thyroid dysfn ? Universal screening not currently recommended: ACOG, AACE, Endo Society, ATA Controversial! Definitely screen: Goitre, FHx thyroid dysfn., prior postpartum thyroiditis, T1DM Ideally, check TSH preconception: mU/L: recheck TSH during 1 st trimester mU/L: do not need to recheck during preg If TSH not done preconception do at earliest prenatal visit: mU/L: hCG effect (9% preg), recheck in 5wk < 0.1 mU/L: recheck immediately with FT4, FT3, T4, T3

17 Thyrotoxicosis & Pregnancy Causes: Graves’ disease TMNG, toxic adenoma Thyroiditis Hydatiform mole Gestational hCG-asscociated Thyrotoxicosis Hyperemesis gravidarum   hCG 60%  TSH, 50%  FT4 Resolves by 20 wks gestation Only Rx with ATD if persists > 20 wk

18 Thyrotoxicosis & Pregnancy Risks: Maternal: stillbirth, preterm labor, preeclampsia, CHF, thyroid storm during labor Fetal: SGA, possibly congenital malformation (if 1 st trimester thyrotoxicosis), fetal tachycardia, hydrops fetalis, neonatal thyrotoxicosis

19 Thyrotoxicosis & Pregnancy Diagnosis difficult: hCG effect: Suppressed TSH (9%) +/-  FT4 (14%) until 12 wks Enhanced if hyperemesis gravidarum: 50-60% with abnormal TSH & FT4, duration to 20 wks FT4 assays reading falsely low T4 elevated due to TBG (1.5x normal) NO RADIOIODINE Measure: TSH, FT4, FT3, T4, T3, thyroid antibodies? Examine: goitre? orbitopathy? pretibial myxedema?

20 Pregnant & Suppressed TSH TSH < 0.1TSH 0.1 – 0.4 Recheck in 5 wks FT4, FT3, T4, T3 Thyroid Ab’s Examine NormalizesStill suppressed Very High TFT’s: TSH undetectable very high free/total T4/T3 hyperthyroid symptoms no hyperemesis TSH-R ab + orbitopathy goitre, nodule/TMNG pretibial myxedema Treat Hyperthyroidism (PTU) Hyperemesis Gravidarum Abnormal TFT’s past 20 wk Don’t treat with PTU

21 Thyrotoxicosis & Pregnancy: Rx No RAI ever (destroy fetal thyroid) PTU Start 100 mg tid, titrate to lowest possible dose Monitor qmos on Rx: T4, T3, FT4, FT3 –TSH less useful (lags, hCG suppression) Aim for high-normal to slightly elevated hormone levels –T nM, T nM, FT pM 3 rd trimester: titrate PTU down & d/c prior to delivery if TFT’s permit to minimize risk of fetal goitre Consider fetal U/S wk to R/O fetal goitre If allergy/neutropenia on PTU: 2 nd trimester thyroidectomy

22 Thyrotoxicosis & Lactation ATD generally don’t get into breast milk unless at higher doses: PTU > mg/d MTZ > 20 mg/d Generally safe I prefer PTU > MTZ for preg  lactating Take ATD dose just after breast-feeding Should provide 3-4h interval before lactates again

23 Neonatal Grave’s Rare, 1% infants born to Graves’ moms 2 types: Transplacental trnsfr of TSH-R ab (IgG) Present at birth, self-limited Rx PTU, Lugol’s, propanolol, prednisone Prevention: TSI in mom 2 nd trimester, if 5X normal then Rx mom with PTU (crosses placenta to protect fetus) even if mom is euthyroid (can give mom LT4 which won’t cross placenta) Child develops own TSH-R ab Strong family hx of Grave’s 3-6 mos 20% mortality, persistant brain dysfunction

24 Postpartum & Thyroid 5% (3-16%) postpartum women (25% T1DM) Up to 1 year postpartum (most 1-4 months) Lymphocytic infiltration (Hashimoto’s) Postpartum  Exacerbation of all autoimmune dx 25-50% persistant hypothyroidism Small, diffuse, nontender goitre Transiently thyrotoxic  Hypothyroid

25

26 Postpartum & Thyroid Distinguish Thyrotoxic phase from Grave’s: No Eye disease, pretibial myxedema Less severe thyrotoxic, transient (repeat thyroid fn 2-3 mos) RAI (if not breast-feeding) Rx: Hyperthyroid symptoms: atenolol mg od Hypothyroid symptoms:LT ug/d to start Adjust LT4 dose for symtoms and normalization TSH Consider withdrawal at 6-9 months (25-50% persistent hypothyroid, hi-risk recur future preg)

27 Postpartum & Thyroid Postpartum depression When studied, no association between postpartum depression/thyroiditis Overlapping symtoms, R/O thyroid before start antidepressents Screening for Postpartum Thyroiditis HOW: TSH q3mos from 1 mos to 1 year postpartum? WHO: –Symptoms of thyroid dysfn. –Goitre –T1DM –Postpartum thyroiditis with prior pregnancy

28 Objectives Thyroid Disorders & Pregnancy Normal thyroid phsyiology & pregnancy Hypothyroidism & pregnancy Thyrotoxicosis & pregnancy Postpartum thyroid dysfunction Diabetes & Pregnancy Gestational DM Type 1 & Type 2 DM & Pregnancy

29 Gestational Diabetes Mellitus (GDM) “Glucose intolerance with onset/discovery during pregnancy” Some T2DM picked up during pregnancy Rarely some T1DM may present during pregnancy Prevalence higher than previously thought in Canada: % non-Aboriginal (but multi-ethnic) population % Aboriginal

30 Gestational Diabetes Mellitus (GDM) Prior “selective screening” resulted in missed cases: Caucassians < 25 y.o. No personal or FHx of DM No prior infant with birth weight > 4 kg Treatment of GDM reduces perinatal morbidity Diagnosis GDM   maternal anxiety ? Evidence controversial for this Therefore all women should be screened

31

32 * Presence of multiple risk factors warrants earlier screening (preconception, 1 st & 2 nd trimester)

33 GDM: Morbidity MaternalFetal/Neonatal Macrosomia (birth trauma,cesarian) Macrosomia (shoulder dystocia) PreeclampsiaRDS PolyhydramniosNeonatal hypoglycemia Perinatal mortality (fetus)Neonatal hypocalcemia Postpartum IFG, IGT, DM 3-6 mos: % Lifetime: % Neonatal jaundice Obesity later in life? IGT, IFG, or DM later in life?

34

35 GDM Treatment CBG qid: FBS, 1-2h pc Dietary: 3 small meals, 3 small snacks If glycemic targets not met: Insulin Multiple Daily Injection (MDI) best Insulins: regular, lispro, aspart ? (still new) No glargine (stimulates IGF-I receptors)

36 GDM Treatment No OHA’s, not standard of care yet. Glyburide Minimal crossing of placenta, 3 rd trimester most organogenesis complete 1 RCT: 404 women, mild GDM, glyburide vs. insulin, no difference in outcomes Further study before safety established Metformin Retrospective cohort:  preeclampsia & stillbirth Bias: DM women older, more obese

37 GDM: Labour & Postpartum NPO during Labour: Monitor CBG q1h, target BS 4 – 6.5 mM Hypoglycemia (BS < 4 mM): IV D5W Hyperglycemia (BS > 6.5 mM): IV D5W & IV insulin gtt Postpartum: D/C all insulin (IV and SC) CBG in recovery: > 10 mM  CBG qid, may need Rx for T2DM < 10 mM  stop CBG monitoring FBS or 2hPG in 75g OGTT within 6 mos postpartum and prior to any future planned pregnancies Encourage: breast feeding, healthy diet, exercise to prevent future Type 2 DM, GDM Screen for future T2DM (GDM is a risk factor)

38

39

40 T1DM, T2DM & Pregnancy Congenital anomalies: 2-3x increased risk Cardiac malformations Neural Tube Defects 1 % risk Folate 1-4 mg/d (Prenatal vitamin mg) d/c ACE-I and ARBs  methyldopa, etc. Dilated eye exam: preconception & 1 st trimester T2DM: d/c OHA  insulin Good glycemic control prior to conception: Prevent unplanned pregnancies: OCP or 2x barrier Initiate MDI and qid (FBS, 2hPC) prior to preg CSII also another option

41 T1DM, T2DM & Pregnancy < 8.0 ?

42 T1DM & T2DM: Labour & Postpartum NPO during Labor: Monitor CBG q1h, target BS 4.0 – 6.5 mM IV D5W & IV insulin gtt (Hamilton Health Sciences Protocol) Postpartum: D/C all IV insulin Insulin resistance/requirements rapidly fall during & after labor T2DM: monitor CBG qid Restart insulin if CBG > 10 mM T1DM: postpartum honeymoon CBG q1h x 4h, then q2h x 4h, then q4h Restart MDI insulin S.C. when CBG > 10 mM No OHA, ACE-I or ARB during breast feeding!

43

44

45 END


Download ppt "Pregnancy & Endocrinology William Harper Hamilton General Hospital McMaster University www.drharper.ca."

Similar presentations


Ads by Google